Ventas, Inc. $VTR Holdings Lifted by Lbp Am Sa

Lbp Am Sa raised its position in Ventas, Inc. (NYSE:VTR) by 17.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 479,818 shares of the real estate investment trust’s stock after purchasing an additional 71,764 shares during the quarter. Lbp Am Sa owned about 0.11% of Ventas worth $33,582,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. True Wealth Design LLC increased its position in Ventas by 1,557.7% in the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock valued at $30,000 after acquiring an additional 405 shares during the period. ORG Partners LLC grew its stake in shares of Ventas by 76.1% in the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 197 shares in the last quarter. Wilmington Savings Fund Society FSB increased its holdings in shares of Ventas by 65.5% during the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock valued at $32,000 after purchasing an additional 180 shares during the period. Ameritas Advisory Services LLC bought a new stake in shares of Ventas during the second quarter valued at about $33,000. Finally, Golden State Wealth Management LLC raised its stake in shares of Ventas by 52.7% during the second quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock valued at $34,000 after purchasing an additional 185 shares in the last quarter. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on VTR. KeyCorp increased their target price on shares of Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a research report on Thursday, December 4th. Scotiabank lifted their target price on Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a report on Thursday, November 13th. Wells Fargo & Company raised their price objective on shares of Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Cantor Fitzgerald reissued an “overweight” rating and set a $93.00 target price on shares of Ventas in a research note on Monday, January 5th. Finally, Weiss Ratings upgraded shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Ventas has a consensus rating of “Moderate Buy” and a consensus target price of $81.63.

Insider Transactions at Ventas

In other news, CFO Robert F. Probst sold 33,591 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $76.77, for a total transaction of $2,578,781.07. Following the completion of the sale, the chief financial officer directly owned 168,364 shares of the company’s stock, valued at $12,925,304.28. This trade represents a 16.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Debra A. Cafaro sold 317,258 shares of the firm’s stock in a transaction that occurred on Thursday, October 30th. The shares were sold at an average price of $74.24, for a total transaction of $23,553,233.92. Following the transaction, the chief executive officer directly owned 1,145,695 shares in the company, valued at approximately $85,056,396.80. The trade was a 21.69% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 494,005 shares of company stock valued at $37,132,767. 1.00% of the stock is owned by insiders.

Ventas Stock Performance

Ventas stock opened at $76.94 on Monday. Ventas, Inc. has a fifty-two week low of $58.72 and a fifty-two week high of $81.89. The firm’s 50 day simple moving average is $78.51 and its 200-day simple moving average is $72.43. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.32 and a quick ratio of 0.32. The company has a market cap of $36.14 billion, a P/E ratio of 147.95, a price-to-earnings-growth ratio of 1.91 and a beta of 0.78.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Wednesday, October 29th. The real estate investment trust reported $0.88 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.01. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.44 billion. Ventas had a net margin of 4.28% and a return on equity of 2.05%. The company’s revenue was up 20.5% on a year-over-year basis. During the same quarter last year, the business posted $0.80 EPS. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. As a group, equities research analysts predict that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st were given a $0.48 dividend. The ex-dividend date was Wednesday, December 31st. This represents a $1.92 dividend on an annualized basis and a yield of 2.5%. Ventas’s dividend payout ratio is presently 369.23%.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.